![]() |
Melbourne, Mar 17, 2011 (ABN Newswire) - Regenerative medicine company Mesoblast Limited (
ASX:MSB) (
PINK:MBLTY) today announced that Chief Executive Officer Professor Silviu Itescu has been named BioSpectrum Asia Pacific Person of the Year 2011. BioSpectrum Asia is the leading Asian life sciences publication.
Bio Spectrum's Chief Editor, Dr Narayanan Suresh, said: "The jury's choice of Professor Silviu Itescu, the key mover behind Australia's Mesoblast, one of the global pioneers in developing treatments using adult stem cells, was unanimous."
The Person of the Year Award was judged on meeting award criteria including performance of the organization, role beyond the company, key projects in 2010, global initiatives, influence on policy making, fostering industry harmony and stature as a leader and visionary. The judging panel comprised six global life sciences industry leaders.
Professor Itescu said he was humbled but proud to receive the prestigious award.
"BioSpectrum has recognized Mesoblast's leadership in the global regenerative medicine industry, the tremendous promise of our proprietary adult stem cells to treat major diseases, and the company's ability to grow through valuable strategic alliances," he said.
"The award is most importantly an affirmation of the tremendous effort and dedication from a highly professional and committed team that is responsible for building Mesoblast into a world leading biopharmaceutical company."
ASX:MSB) (
PINK:MBLTY) today announced that Chief Executive Officer Professor Silviu Itescu has been named BioSpectrum Asia Pacific Person of the Year 2011. BioSpectrum Asia is the leading Asian life sciences publication.Bio Spectrum's Chief Editor, Dr Narayanan Suresh, said: "The jury's choice of Professor Silviu Itescu, the key mover behind Australia's Mesoblast, one of the global pioneers in developing treatments using adult stem cells, was unanimous."
The Person of the Year Award was judged on meeting award criteria including performance of the organization, role beyond the company, key projects in 2010, global initiatives, influence on policy making, fostering industry harmony and stature as a leader and visionary. The judging panel comprised six global life sciences industry leaders.
Professor Itescu said he was humbled but proud to receive the prestigious award.
"BioSpectrum has recognized Mesoblast's leadership in the global regenerative medicine industry, the tremendous promise of our proprietary adult stem cells to treat major diseases, and the company's ability to grow through valuable strategic alliances," he said.
"The award is most importantly an affirmation of the tremendous effort and dedication from a highly professional and committed team that is responsible for building Mesoblast into a world leading biopharmaceutical company."
| Tweet |
About Mesoblast Limited
Mesoblast Limited (ASX:MSB) (OTC ADR: MBLTY) is the world's leading developer of innovative biological products for the broad field of regenerative medicine.
Mesoblast's commercial strategy is based on its unique proprietary adult mesenchymal precursor cells.
The company's lead products will target cardiovascular conditions, diabetes, inflammatory conditions of lungs and joints, eye diseases, bone marrow cancers, bone fractures, cartilage degeneration and musculoskeletal conditions.
Mesoblast and global biopharmaceutical company Cephalon Inc. have established a strategic alliance to commercialize adult stem cell products for degenerative conditions of the cardiovascular and central nervous systems. The alliance also extends to products for augmenting bone marrow transplantation in cancer patients.
|
||
|
![]() |
Related Companies |
>>> |
![]() |
Related Industry Topics: |
Biotech | Financial General | Health & Pharm General | |
![]() |
This Page Viewed: (Last 7 Days: 120) (Last 30 Days: 930) (Since Published: 21010) |
Site Search
| ENGLISH All Languages |
Upcoming WebCasts
| Mr Mark Paton CEO Cue Energy Resources Tuesday, June 12, 2012 |
| Mr Alan Hopkins CEO Pan Asia Corporation Tuesday, June 12, 2012 |
| Mr Barry Dawes Martin Place Securities Tuesday, June 12, 2012 |
| Dr Andrea Grant CEO Living Cell Technologies Monday, July 02, 2012 |
Companies in the News
Mobile Video TV
|
||
|
||









